Post-Conference - Y90 Dosimetry

Monday, November 16, 2026

A complimentary hands-on workshop—supported by an educational grant from Sirtex—focused on Y90 dosimetry. Learn key planning models, review outcome-driven data, and practice with MIM Y90 and the Cancer Y90 app to optimize treatment planning and improve patient outcomes.

For the first 40 individuals to register for the CIO Post-Conference, the grantor will cover 1 hotel night for use on November 15, 2026. To qualify for this offer, just select the box indicating you need a hotel room during registration checkout.

Please note that this offer is not applicable for Industry.

In one day, you'll

  • Master clinically relevant dosimetry models
  • Review the latest evidence on outcomes and toxicity
  • Gain hands-on experience with MIM Y90 Dosimetry Software and the Cancer Y90 App
  • Practice treatment planning across multiple clinical scenarios
  • Leave with practical techniques you can apply immediately

Post-Conference Agenda | 7:30 AM - 3:15 PM

7:30 – 8:00 AM: Arrival, Sign in, Welcome

8:00 – 10:00 AM: Session 1

  • 8:00 – 8:10: Clinically Practical Dosimetry Models — Alex Villalobos
  • 8:10 – 8:15: Discussion and Q&A
  • 8:15 – 8:25: Importance of Particle Density and Dose Distribution — Nima Kokabi
  • 8:25 – 8:30: Discussion and Q&A
  • 8:30 – 8:40: Important Contemporary Glass and Resin Dosimetry Studies — Zachary Berman
  • 8:40 – 8:45: Discussion and Q&A
  • 8:45 – 8:55: Understanding Resin FLEXDose Delivery Program, Order-Map-Treat — Ripal Gandhi
  • 8:55 – 9:00: Discussion and Q&A
  • 9:00 – 9:10: Understanding Any Day Dosing and Ordering Glass Surplus Doses — Venkatesh Krishnasamy
  • 9:10 – 9:15: Discussion and Q&A
  • 9:15 – 9:25: Ideal Patient Selection / Considerations (and Patients to Avoid) — Ghassan El-Haddad
  • 9:25 – 9:30: Discussion and Q&A
  • 9:30 – 9:40: Intro to Tools, Imaging and Procedural Set Up — Asad Baig
  • 9:40 – 9:45: Discussion and Q&A
  • 9:45 – 9:55: Managing High Lung Shunts — Ripal Gandhi
  • 9:55 – 10:00: Discussion and Q&A

10:00 – 10:15 AM: Refreshment Break

10:15 AM – 12:15 PM: Session 2

  • 10:00 – 10:10: Prevention and Management of Complications — Ripal Gandhi
  • 10:10 – 10:15: Discussion and Q&A
  • 10:15 – 10:25: Y90 Plus Systemic Therapy: Where Are We and Where Are We Going? — Zachary Berman
  • 10:25 – 10:30: Discussion and Q&A
  • 10:30 – 10:40: Competitive Treatments – Y90 Benefits vs. Other LDT Therapies — Ghassan El-Haddad
  • 10:40 – 10:45: Discussion and Q&A
  • 10:45 – 10:55: Various Chemo Agents That You Will Encounter — Venkatesh Krishnasamy
  • 10:55 – 11:00: Discussion and Q&A
  • 11:00 – 11:10: Advanced Flow Modulation Techniques to Allow Conformal Delivery — Venkatesh Krishnasamy
  • 11:10 – 11:15: Discussion and Q&A
  • 11:15 – 11:25: New Innovations in Y90 Therapy — Zachary Berman
  • 11:25 – 11:30: Discussion and Q&A
  • 11:30 – 11:40: Utility of Single Session Y90 Treatment — Nima Kokabi
  • 11:40 – 11:45: Discussion and Q&A
  • 11:45 – 11:55: Tumor Board / MDT – How Do I position Y90 as a Treatment Option? — Alex Villalobos
  • 11:55 – 12:00: Discussion and Q&A
  • 12:00 – 12:10: Pathways to Becoming an Authorized User for Y90 — Asad Baig
  • 12:10 – 12:15: Discussion and Q&A

12:15 – 12:45 PM: Lunch

12:45 – 3:15 PM: Hands-On Dosimetry (non-accredited)

Back to top